Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Vasilis P. Bozikas"'
Autor:
Emilia Vassilopoulou, Dimitris Efthymiou, Vasilis Tsironis, Panayiotis Athanassis, Stelios Chatzioannidis, Theano Kesoglou, Andrey V. Severin, Vasilis P. Bozikas
Publikováno v:
Toxicology Reports, Vol 9, Iss , Pp 120-125 (2022)
Background: The side effects of antipsychotics (APs), related to weight gain and metabolic disturbances, can contribute to the health burden of psychotic people. Objective: To explore a) the level of adherence to the Mediterranean Diet (MedDiet) and
Externí odkaz:
https://doaj.org/article/6601b5442d65456ab0a45c4a3049c1fb
Autor:
Katalin Pungor, Vasilis P. Bozikas, Robin Emsley, Pierre-Michel Llorca, Srihari Gopal, Maju Mathews, Annette Wooller, Paul Bergmans
Publikováno v:
Therapeutic Advances in Psychopharmacology, Vol 10 (2020)
Background: Paliperidone palmitate 3-monthly (PP3M) is a second-generation, long-acting injectable antipsychotic formulation indicated for the maintenance treatment of adults with schizophrenia first stabilized with paliperidone palmitate 1-monthly (
Externí odkaz:
https://doaj.org/article/b3fa4be270c14f9fa42165c0eeb276ea
Autor:
Maria Paz Garcia-Portilla, Pierre-Michel Llorca, Giuseppe Maina, Vasilis P. Bozikas, Halise Devrimci-Ozguven, Sung-Wan Kim, Paul Bergmans, Irina Usankova, Katalin Pungor
Publikováno v:
Therapeutic Advances in Psychopharmacology, Vol 10 (2020)
Background: Paliperidone palmitate 3-monthly (PP3M) formulation is a long-acting, injectable antipsychotic treatment approved in many countries worldwide for the maintenance treatment of adult patients with schizophrenia. This single-arm, open-label,
Externí odkaz:
https://doaj.org/article/9b1afb3a4e6044e6b005a52cf7c7ab9a
Autor:
Mary H. Kosmidis, Vasilis P. Bozikas, Vaitsa Giannouli, Athanasios Karavatos, Konstantinos Fokas
Publikováno v:
Behavioural Neurology, Vol 25, Iss 4, Pp 341-349 (2012)
Our purpose in undertaking the present study was to examine the hypotheses proposed for explaining the frequent comorbidity of bipolar disorder and multiple sclerosis. One hypothesis posits that, when there is comorbidity, MS plays a causal role in p
Externí odkaz:
https://doaj.org/article/9901e5fb97ff40f4984991e9a0081771
Autor:
Marco Solmi, Konstantinos Tsamakis, Agorastos Agorastos, Vasilis P. Bozikas, Christoph U. Correll
Publikováno v:
Psychiatrike = Psychiatriki. 32(1)
As of the end of 2020, the COVID-19 pandemic has led to over 82 million verified infections and almost 1.8 million COVID-19-related deaths worldwide,1 resulting to an unprecedented public health response around the globe. The COVID-19 pandemic, toget
Autor:
Sung-Wan Kim, Pierre-Michel Llorca, Halise Devrimci-Ozguven, Paul Bergmans, María Paz García-Portilla, Irina Usankova, Katalin Pungor, Giuseppe Maina, Vasilis P. Bozikas
Publikováno v:
Therapeutic Advances in Psychopharmacology, Vol 10 (2020)
WOS:000537860000001
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
Therapeutic Advances in Psychopharmacology
RUO: Repositorio Institucional de la Universidad de Oviedo
Universidad de Oviedo (UNIOVI)
WOS:000537860000001
RUO. Repositorio Institucional de la Universidad de Oviedo
instname
Therapeutic Advances in Psychopharmacology
RUO: Repositorio Institucional de la Universidad de Oviedo
Universidad de Oviedo (UNIOVI)
Background: Paliperidone palmitate 3-monthly (PP3M) formulation is a long-acting, injectable antipsychotic treatment approved in many countries worldwide for the maintenance treatment of adult patients with schizophrenia. This single-arm, open-label,
Autor:
Robin Emsley, Annette Wooller, Paul Bergmans, Maju Mathews, Katalin Pungor, Srihari Gopal, Pierre-Michel Llorca, Vasilis P. Bozikas
Publikováno v:
Therapeutic Advances in Psychopharmacology, Vol 10 (2020)
Background: Paliperidone palmitate 3-monthly (PP3M) is a second-generation, long-acting injectable antipsychotic formulation indicated for the maintenance treatment of adults with schizophrenia first stabilized with paliperidone palmitate 1-monthly (
Autor:
Amalia Alexiadou, Mary H. Kosmidis, Eleni Parlapani, Grigoris Kiosseoglou, Konstantinos Fokas, Vasilis P. Bozikas
Publikováno v:
Comprehensive Psychiatry, Vol 80, Iss, Pp 81-88 (2018)
Objectives Autobiographical memory (AM) involves recollection of personal events and facts about one's life. Αim of the present study was to investigate AM in schizophrenia patients, and, in particular, patients' ability to recall autobiographical m
Publikováno v:
Journal of behavior therapy and experimental psychiatry. 68
Background and objectives Individualized Metacognitive Training (MCT+) is a manualized intervention designed to improve delusional severity by reducing delusion-associated cognitive biases such as jumping-to-conclusions. Increased interest in persona
Autor:
Eleni Parlapani, Eleni Skemperi, Amalia Alexiadou, Georgios Floros, Eugenia Dandi, Elena I. Nazlidou, Vasilis P. Bozikas, Georgios Garyfallos, Stavroula I. Bargiota
Publikováno v:
Psychiatry research. 278
Autobiographical memory (AM) has been studied extensively in different psychiatric disorders. However, less is known about AM in bipolar disorder (BD). Aim of the present study was to investigate BD patients' ability to recall episodic and semantic a